Total Payments
$4,086
2024 Payments
$288.29
Companies
23
Transactions
252
Medicare Patients
547
Medicare Billing
$59,240
Payment Breakdown by Category
Food & Beverage$4,086 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,086 | 252 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,033 | 76 | $0 (2024) |
| Novo Nordisk Inc | $737.18 | 47 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $503.30 | 27 | $0 (2024) |
| Lilly USA, LLC | $407.17 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $291.88 | 14 | $0 (2023) |
| Merck Sharp & Dohme LLC | $145.13 | 10 | $0 (2023) |
| GlaxoSmithKline, LLC. | $124.47 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $115.40 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $100.49 | 6 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $99.10 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $288.29 | 18 | ABBVIE INC. ($141.34) |
| 2023 | $1,538 | 95 | ABBVIE INC. ($447.05) |
| 2022 | $1,125 | 70 | ABBVIE INC. ($312.43) |
| 2021 | $1,134 | 69 | Novo Nordisk Inc ($378.37) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PSYCHIATRY | ||||||
| 04/26/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 01/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: UROLOGY | ||||||
| 12/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 407 | 691 | $115,573 | $46,032 |
| 2022 | 4 | 140 | 174 | $31,880 | $13,208 |
Total Patients
547
Total Services
865
Medicare Billing
$59,240
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 287 | $54,530 | $19,730 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 60 | 60 | $13,500 | $6,303 | 46.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 14 | 65 | $8,431 | $5,212 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 92 | $14,720 | $4,565 | 31.0% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 21 | 81 | $6,883 | $3,781 | 54.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 30 | $9,000 | $3,170 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,750 | $1,382 | 36.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 21 | 21 | $2,940 | $1,292 | 43.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 22 | 22 | $1,100 | $328.90 | 29.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $720.00 | $269.10 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 103 | $19,570 | $8,075 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 42 | $6,720 | $2,481 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $4,050 | $1,922 | 47.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 11 | 11 | $1,540 | $730.03 | 47.4% |
About Holly Mansur, FNP-C
Holly Mansur, FNP-C is a Family healthcare provider based in Abilene, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2017. The National Provider Identifier (NPI) number assigned to this provider is 1982113874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Holly Mansur, FNP-C has received a total of $4,086 in payments from pharmaceutical and medical device companies, with $288.29 received in 2024. These payments were reported across 252 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,086).
As a Medicare-enrolled provider, Mansur has provided services to 547 Medicare beneficiaries, totaling 865 services with total Medicare billing of $59,240. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Hospice, Family
- Location Abilene, TX
- Active Since 09/24/2017
- Last Updated 07/19/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1982113874
Products in Payments
- VRAYLAR (Drug) $567.92
- Ozempic (Drug) $444.90
- FARXIGA (Drug) $439.20
- JARDIANCE (Drug) $395.61
- TRULICITY (Drug) $268.22
- QULIPTA (Drug) $242.36
- Rybelsus (Drug) $173.89
- UBRELVY (Drug) $150.68
- TRELEGY ELLIPTA (Drug) $124.47
- REXULTI (Drug) $115.40
- BELSOMRA (Drug) $112.08
- QUVIVIQ (Drug) $99.10
- SOLIQUA 100/33 (Biological) $86.36
- XARELTO (Drug) $78.32
- ENTRESTO (Drug) $73.75
- BREZTRI (Drug) $64.10
- ELIQUIS (Drug) $58.88
- Saxenda (Drug) $44.11
- XIFAXAN (Drug) $36.95
- Horizant (Drug) $34.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Abilene
Sandra Flores, Np, NP
Family — Payments: $4,903
Family $4,903
Teresa Sowa, Np-C, NP-C
Family — Payments: $4,749
Family $4,749
Mrs. Kathryn Barton, Rn, Fnp-C, RN, FNP-C
Family — Payments: $4,681
Family $4,681
Linda Larsen, Rn Np-C, RN NP-C
Family — Payments: $4,675
Family $4,675
Rachel Brown, Aprn Fnp-C, APRN FNP-C
Family — Payments: $3,511
Family $3,511
Zarina Calingo, Np-C, NP-C
Family — Payments: $3,323
Family $3,323